Thank You
Your form was submitted successfully!
Our Apologies...
An error has occurred while submitting. Please try again later...
Protect. Beyond with PREVENA™ Therapy
The impact of COVID-19 has increased focus in healthcare facilities on managing patient care with a sharp eye on resources. With an emphasis on improving OR efficiency, minimising prolonged stays, reducing re-admissions and preventable complications is vital to patient flow and facility economics. As you look for solutions that provide extended value, learn how PREVENA™ Therapy can help protect you, your patients, and your practice beyond the incision site.
-
PREVENA™ Therapy manages and protects surgical incisions in high risk patients. Under -125mmHg of negative pressure, the Reticulated Open Cell Foam dressing collapses to its geometric center, bringing incision edges together to reduce lateral tension and improve fluid management.
-
The most clinically validated closed incision negative pressure therapy with over 80+ publications and growing, PREVENA™ Therapy can aid in reducing the costly financial burden of complications such as SSIs.
-
PREVENA™ Therapy helps provide protection from outside sources of infection, ensuring the effective management and healing of surgical incisions in patients.
Contact a 3M Representative to learn how PREVENA™ Therapy can benefit your patients and practice.
REQUEST A DEMONSTRATION
How PREVENA™ Therapy works
Now more than ever.
Learn how PREVENA™ Therapy is uniquely engineered to empower incision management that works to protect patients, surgeons, staff, practices and hospitals during the COVID-19 pandemic.
-
PREVENA™ Therapy for PatientsAccess information and patient stories to share with your patients.
-
Medical EducationFind educational resources to help deepen your expertise and enhance patient care and safety in surgical settings.
Call us on 1800 742 9929
Subscribe to receive the latest 3M Medical news, events and information.
-
*PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units are intended to aid in reducing the incidence of seroma and, in patients at risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and II wounds.
-
The effectiveness of PREVENA™ Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at ##discLink1##.
